Medicines

The medicines sector is characterised by a few large pharmaceutical companies and a large number of SME “biotech” companies.

Support for companies of all sizes is provided by the Health Team across the sector but particularly linked with the manufacturing of pharmaceuticals and advanced therapeutics. Members of the Health Team are closely aligned with the Medicines Manufacturing Industry Partnership and the Bioindustry Association.

KTN also organises the Medicines Manufacturing Challenge Community. Its core goal is to accelerate the outcomes from the medicines manufacturing ISCF Challenge which has seen £146m invested in different projects, including the Medicines Manufacturing Innovation Centre and Advanced Therapy Treatment Centres.

Our Medicines Expert

Karen Wilkinson

Read full profile

Funding Opportunities

Biomedical catalyst 2021: early and late stage awards

UK registered organisations can apply for a share of up to £18 million to develop innovative healthcare products, technologies, and processes.

Opens: 07/06/2021 Closes: 26/08/2021

Explore Further

Horizon Europe Work Programme 2021-2022: Health Cluster 1

Horizon Europe has a wide variety of open calls for healthcare, with closing dates in September 2021, April 2022 and September 2022. These include tackling diseases and reducing disease burden, staying healthy, health industry, health care, new technologies and digital solutions for a healthy society, and health-promoting environment.

Opens: 12/07/2021 Closes: 06/09/2022

Explore Further

View All Funding Opportunities

Recorded: 31st March

Medicines Manufacturing Challenge Community Event 2021

This Medicines Manufacturing Challenge Community showcase event, delivered by Knowledge Transfer Network, is an opportunity to learn more about the latest projects and the research and infrastructure developments that will accelerate the development and manufacture of vital advanced therapies, medicines and vaccines.

Watch Now

News

08.04.2021

Horizon Europe Cluster 1: Health

Horizon Europe is the next European Funding Framework Programme following on from its predecessor Horizon 2020. It will run for seven years from 2021 to 2027. The total budget set for the programme is €95.5 billion. There are six Clusters under Pillar 2: Global Challenges and European Industrial Competitiveness. Health is Cluster 1.

29.06.2021

Medicines Manufacturing Challenge Community Summer Update

Take a look at the latest news, events and funding of relevance to the Medicines Manufacturing community in our round-up.

View All Related News

Programmes related to Medicines

View all our programmes

Medimap: End-to-end medicines supply chain map

Medimap is a new interactive reference tool for the UK medicines sector, mapping and categorising over 3,000 sites of organisations engaged in or supporting the end-to-end supply chain for medicines.

Learn More

Medicines Manufacturing Challenge Community

Supporting manufacturers of medicines in order to grow the UK economy